Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q2 2025
Institutional positions in Calidi Biotherapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q1 2025
- Shares held
- 2.86M
- −2.60M (−47.7%) vs. Q1 2025
- Total value
- $655.8K
- −$2.44M (−78.8%) vs. Q1 2025
- New holders
- 5
- 5 more added
- Sold out
- 6
- 6 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $655.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.53M |
| Q4 2023 | 25 | $2.83M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $39.0M |
| Q1 2023 | 27 | $40.6M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $205.5M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $164.7M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 63 | $14 | 0.00% | +63 | New |
| BlackRock, Inc. | 259 | $60 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 326 | $75 | 0.00% | +104+46.8% | Added |
| CVA Family Office, LLC | 500 | $115 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 560 | $129 | 0.00% | +260+86.7% | Added |
| Tradewinds Capital Management, LLC | 1,000 | $230 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,919 | $441 | 0.00% | −100−5.0% | Reduced |
| Barrett & Company, Inc. | 3,500 | $805 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Evermay Wealth Management LLC | 6,342 | $1.46K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,240 | $2.00K | 0.00% | −44,497−81.3% | Reduced |
| Grassi Investment Management | 10,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,937 | $2.06K | 0.00% | +3,821+74.7% | Added |
| Avidian Wealth Solutions, LLC | 10,000 | $2.30K | 0.00% | 00.0% | Unchanged |
| Finepoint Capital LP | 12,499 | $2.88K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 12,501 | $2.88K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 13,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 13,205 | $3.04K | 0.00% | +13,205 | New |
| Delta Investment Management, LLC | 21,023 | $4.83K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 26,753 | $6.15K | 0.00% | +7,500+39.0% | Added |
| Raymond James Financial Inc | 31,100 | $7.15K | 0.00% | +31,100 | New |
| HRT Financial LP | 43,609 | $10.0K | 0.00% | +43,609 | New |
| UBS Group AG | 44,902 | $10.3K | 0.00% | +44,901+4,490,100.0% | Added |
| Drive Wealth Management, LLC | 45,000 | $10.3K | 0.00% | −10,000−18.2% | Reduced |
| Northern Trust Corp | 48,693 | $11.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 61,290 | $14.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 71,196 | $16.4K | 0.00% | +71,196 | New |
| Red Wave Investments LLC | 80,828 | $18.6K | 0.01% | 00.0% | Unchanged |
| CPR Investments Inc. | 101,000 | $23.2K | 0.02% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 119,471 | $27.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 232,576 | $53.5K | 0.00% | −19,340−7.7% | Reduced |
| Belpointe Asset Management LLC | 249,833 | $57.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 353,380 | $81.3K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 422,500 | $97.2K | 0.00% | −67,300−13.7% | Reduced |
| Armistice Capital, LLC | 792,000 | $182.2K | 0.01% | −2,530,000−76.2% | Reduced |
| RS Crum Inc. | 0 | $0 | 0.00% | −55,313−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −32,642−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,259−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,034−100.0% | Sold out |
| Apollo Management Holdings, L.P. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |